Swedish medtech innovator H100 Group has made a strategic leap forward by securing up to 750M SEK ($79M) in convertible debt financing from Blockstream CEO Adam Back. This substantial investment will accelerate the company's blockchain and Bitcoin integration initiatives.
For more details about this strategic partnership, read about H100 Group and Blockstream's $79M convertible loan agreement for Bitcoin strategy.
The financing arrangement is structured in multiple tranches, with an initial disbursement of 150M SEK ($15M) already completed. Subsequent stages will release minimum increments of 75M SEK each, providing H100 Group with flexible capital access as it executes its technology roadmap.
A notable feature of the deal is the conversion option at 6.38 SEK per share, offering investors potential equity upside while giving H100 Group advantageous terms for strategic capital management. Company representatives emphasized how this structure enables both financial flexibility and opportunities for future partnerships.
This funding marks a significant milestone in H100 Group's evolution from pure medtech player to technology innovator at the intersection of healthcare and blockchain solutions.